Zydus Lifesciences plans growth through specialty medicines

What happened

Zydus Lifesciences aims for double-digit revenue growth over the next five years.
The company is shifting focus toward specialty medicines and biotechnology.
The company expects discovery-led products to contribute to earnings from 2030.

Original source

The Economic Times

Was this summary clear?

For information only — not investment advice.Summarized automatically; always check the original before acting.